Virginia Cancer Specialists

Manassas, Virginia 20110

2 studies enrolling now · 3 studies all time

What they study most

Acute Myeloid Leukemia (AML), Breast Cancer, Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma

Studies at this site

• Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML — Recruiting now
• A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. — Recruiting now
• A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia — Running, not enrolling